financetom
Business
financetom
/
Business
/
Paramount Resources raises 2025 sales guidance after Alhambra start-up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paramount Resources raises 2025 sales guidance after Alhambra start-up
Jul 30, 2025 5:07 AM

Overview

* Paramount Q2 sales volumes averaged 31,631 Boe/d, 46% liquids

* Company revises 2025 sales volumes guidance upwards due to early Alhambra Plant start-up

* Free cash flow was negative C$86 mln, but company maintains strong cash position

Outlook

* Paramount revises 2025 sales volumes to 38,500-42,500 Boe/d

* Company expects Q4 sales volumes of 42,000-45,000 Boe/d

* Paramount anticipates 2025 exit rate over 45,000 Boe/d

* Capital expenditure guidance unchanged at C$780-C$840 mln for 2025

Result Drivers

* DUVERNAY PRODUCTION - Duvernay production accounted for 56% of total sales volumes, driving sales in Central Alberta

* CAPITAL EXPENDITURES - Significant investment in drilling and completing Duvernay wells to enhance future production

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Net C$4.20

Income mln

Q2 Free -C$85.50

Cash mln

Flow

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the oil & gas exploration and production peer group is "buy"

* Wall Street's median 12-month price target for Paramount Resources Ltd ( PRMRF ) is C$24.50, about 11% above its July 29 closing price of C$21.80

* The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 4 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Blend to Provide Automation Services to PenFed Lending Operations
Blend to Provide Automation Services to PenFed Lending Operations
Oct 17, 2024
04:57 PM EDT, 10/14/2024 (MT Newswires) -- Blend (BLND) said Monday it will provide loan origination automation services to PenFed Credit Union's home lending operations. The origination platform will also provide tools to PenFed's loan officers to help serve its members. Terms of the partnership weren't disclosed. ...
Modine Manufacturing Names Dan Hedstrom as CIO
Modine Manufacturing Names Dan Hedstrom as CIO
Oct 17, 2024
04:56 PM EDT, 10/14/2024 (MT Newswires) -- Modine Manufacturing ( MOD ) appointed Dan Hedstrom as chief information officer, effective immediately. Hedstrom takes over from Steve Langer, the current vice president of information technology, who plans to retire at the end of this year, the company said Monday in a statement. Hedstrom was most recently CIO at Cubic. ...
Houston law firm plans $50 million lawsuit against Pemex
Houston law firm plans $50 million lawsuit against Pemex
Oct 17, 2024
HOUSTON, Oct 14 (Reuters) - A prominent Houston law firm said on Monday it plans to file a lawsuit later this week against Mexican national oil company Pemex seeking $50 million in damages for a deadly hydrogen sulfide gas release on Thursday that killed two workers. We anticipate filing our lawsuit in the next day or two, said Ryan Pigg,...
Sight Sciences' TearCare Treatment Improves Symptoms of Dry Eye Disease in Trial
Sight Sciences' TearCare Treatment Improves Symptoms of Dry Eye Disease in Trial
Oct 17, 2024
04:56 PM EDT, 10/14/2024 (MT Newswires) -- Sight Sciences ( SGHT ) said Monday its TearCare treatment improved symptoms of people with dry eye disease and functional visual outcomes in a trial. A new study called Impact of TearCare on Reading Speed in Patients with Dry Eye Disease has been published in the medical journal Clinical Ophthalmology, the company said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved